New AIDS drug discoveries to battle drug-resistant HIV strains

NEW BRUNSWICK/PISCATAWAY, N.J. Belgian and American scientists have collaborated in discovering several new potential anti-AIDS drugs, including compounds that can block all known drug-resistant strains of the virus. While current anti-HIV therapies have saved lives, the emergence of drug-resistant strains of the rapidly mutating virus has been a major obstacle to successful long-term treatment.

Two of the new drugs, Dapivirine (also called R147681 or TMC120) and R165335 (also called TMC125), are derived from the dianilinopyrimidine (DAPY) family of highly potent compounds. Both have shown great promise in Phase I and Phase II clinical trials.

Dapivirine, based on its ease of manufacture and low cost, is a viable candidate for treating AIDS in the developing world, home to 95 percent of all HIV-infected patients, the researchers said. It is also being tested as a microbicide to prevent the transmission of HIV.

A third compound (R278474), scheduled for Phase I trials, is even more active against common HIV strains and all the mutants tested, according to the researchers.

The team developing the drugs includes scientists from Rutgers, The State University of New Jersey, and the National Institutes of Health (NIH) in the United States; and from Janssen Pharmaceutica in the United States and Belgium and Tibotec-Virco, N.V. in Belgium, both subsidiaries of Johnson & Johnson.

In a presentation at the 224th American Chemical Society (ACS) national meeting in Boston (MEDI 206), Bart De Corte of Janssen Pharmaceutica described the drugs and Paul Lewi of the Center for Molecular Design (CMD) at Janssen Pharmaceutica in Belgium discussed the strategies used to design the drug molecules.

The research effort, which has been conducted under the overall guidance of Dr. Paul Janssen, began more than 10 years ago. Janssen, founder of Janssen Pharmaceutica, has been a leader in drug discovery and has developed drugs u

Contact: Joseph Blumberg
732-932-7084 x652
Rutgers, the State University of New Jersey

Page: 1 2 3

Related biology news :

1. Archaeologists announce discoveries at the ancient Maya site of Waka in northern Guatemala
2. Pioneering discoveries, pursuing new knowledge, fostering partnerships
3. Bacteria discoveries could resemble Mars, other planets
4. Scientists, physicians discuss latest discoveries for stopping cancer before it starts
5. SPR Annual Meeting features newsworthy discoveries
6. Dual discoveries in genetic processing improve accuracy of genome information
7. New discoveries about old-growth forests
8. New Jersey chemist wins national award for drug discoveries
9. Dinosaur discoveries in Montana
10. Worlds largest scientific society to honor DuPont scientists for 2 breakthrough discoveries
11. Los Angeles chemist wins national award for thin-film discoveries

Post Your Comments:

(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: